Affimed

Youtube Subscribe

Open: 0.37 Close: 0.37 Change: 0.0

How to get informed about Affimed quickly using an AI.

This document will help you to evaluate Affimed without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Affimed are: Affimed, Monday, NV, Q3, result, earnings, call, and the …

Concept Map

Semantic Network

Stock Summary

Affimed reveals 25% of staff were let go in april. AffimED reveals 25 per cent of staff let go. AffIMed reveals that 25% were let off in aprils..

Today's Summary

Affimed N.V. 2023 Q3 - results - earnings call presentation (nasdaq:afmd) | seeking alpha.com. Affimeds data for experimental Hodgkins therapy is validating. Affimed has a 52-week low of $0.22 and a 52.week high of $2.38. Cantor Fitzgerald reissued an “overweight” rating and issued a $7.00 price objective on Monday, September 25th. StockNews.com started coverage on Affiming in a report on Monday. Affimed (NASDAQ: AFMD) is $ 0.367199 last updated Today at November 17, 2023 at 4:06 PM UTC. The company is in the Healthcare sector and Biotechnology industry.

Today's News

Affimed N.V. 2023 Q3 - results - earnings call presentation (nasdaq:afmd) | seeking alpha.com. Affimeds data for experimental Hodgkins therapy is validating. Affimed has a 52-week low of $0.22 and a 52.week high of $2.38. Cantor Fitzgerald reissued an “overweight” rating and issued a $7.00 price objective on Monday, September 25th. StockNews.com started coverage on Affiming in a report on Monday. Affimed (NASDAQ: AFMD) is $ 0.367199 last updated Today at November 17, 2023 at 4:06 PM UTC. The company is in the Healthcare sector and Biotechnology industry.

Stock Profile

" Affimed reveals 25% of staff were let go in april. affimed - afmd - stock price today - zacks.com."

Keywords

Are looking for the most relevant information about Affimed? Investor spend a lot of time searching for information to make investment decisions in Affimed. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Affimed are: Affimed, Monday, NV, Q3, result, earnings, call, and the most common words in the summary are: inc, corp, group, holding, ltd, therapeutic, technology, . One of the sentences in the summary was: Affimeds data for experimental Hodgkins therapy is validating. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #inc #corp #group #holding #ltd #therapeutic #technology.

Read more →

Youtube Subscribe

---